Please use this identifier to cite or link to this item:
http://bibliotecadigital.economia.gov.br/handle/123456789/527814
Title: | Balanço da estratégia de desenvolvimento da biotecnologia farmacêutica no Brasil: 2009-2019 |
Authors: | Meirelles, Beatriz Barbosa Pimentel, Vitor Paiva Cruz, Adriana Inhudes Gonçalves da Reis, Carla Banco Nacional de Desenvolvimento Econômico e Social (Brasil). Gabinete da Presidência. Departamento de Divulgação. Gerência de Editoração |
Keywords: | Banco Nacional de Desenvolvimento Econômico e Social (Brasil) - Financiamento Brazilian Development Bank - Financing FINEP BNDES Funtec BNDES Profarma BNDES Support Program to Develop the Industrial Health Sector Sistema Único de Saúde (Brasil) Sistema Único de Saúde (Brazil) Indústria farmacêutica - Brasil - 2009-2019 Pharmaceutical industry - Brazil - 2009-2019 Biotecnologia farmacêutica - Brasil - 2009-2019 Pharmaceutical biotechnology - 2009-2019 Política industrial - Brasil - 2004-2014 Industrial policy - Brazil - 2004-2014 Saúde Health Política pública Public policy Inovação Innovation Pesquisa e desenvolvimento Research and development |
Issue Date: | Mar-2020 |
Publisher: | Banco Nacional de Desenvolvimento Econômico e Social |
Abstract: | Pharmaceutical biotechnology has created opportunities for the treatment of rare and complex diseases, and has become strategic for innovation policies worldwide, including Brazil. The Brazilian scientific vocation for molecular biology and genomics gave rise to several public policies to internalize specific productive capacity and advance the development of innovative products. The gradual incorporation of those drugs in the Unified Health System (SUS) reinforced the need to spread the use of biosimilars and internalize their production; thus, guaranteeing a stable offer at competitive prices. BNDES contributed to the formulation and application of these policies by financing productive plants and product development; BNDES also participated in collegiate bodies and published articles since 2009. This study aims to analyze the Bank's evolution, focusing on the following axes: public procurement, financing, and regulation. |
URI: | http://bibliotecadigital.economia.gov.br/handle/123456789/527814 |
Other Identifiers: | MEIRELLES, Beatriz Barbosa et al. Balanço da estratégia de desenvolvimento da biotecnologia farmacêutica no Brasil: 2009-2019 = Pharmaceutical biotechnology industrial development: an assessment of Brazil’s strategy from 2009 to 2019. BNDES Setorial, Rio de Janeiro, v. 26, n. 51, p. 7-75, mar. 2020. http://web.bndes.gov.br/bib/jspui/handle/1408/19802 |
Appears in Collections: | Produção BNDES - Artigos |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.